Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma

Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma

Abstract Background CD276 is an immune checkpoint molecule. Elevated CD276 expression by urothelial carcinoma is associated with poor prognosis, but little is known about its expression across different tumor stages. We therefore investigated CD276 expression in bladder cancer (BC) cells and in tiss...

Full description

Bibliographic Details
Main Authors: Wilhelm K. Aicher, M. Korn, L. Reitnauer, F. B. Maurer, J. Hennenlotter, P. C. Black, T. Todenhofer, J. Bedke, A. Stenzl
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Urology
Subjects:
Urothelial carcinoma
Immune check-point protein
CD276
B7-H3
Bladder tumor stages
Online Access:https://doi.org/10.1186/s12894-021-00829-0

Internet

https://doi.org/10.1186/s12894-021-00829-0

Similar Items